Name: UMIN ID:
Unique ID issued by UMIN | UMIN000005691 |
---|---|
Receipt number | R000006731 |
Scientific Title | Evaluation of the efficacy and safety of intravitreal injection of ranibizumab every other month for age-related macular degeneration |
Date of disclosure of the study information | 2011/06/01 |
Last modified on | 2017/12/27 16:04:14 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/06/01 08:18:00 | ||
2 | Update | 2012/11/11 15:27:04 | Post marketing survey by drug manufacture etc., specified by Japanese law. Institutions |
|
3 | Update | 2012/11/11 15:27:29 | Publication of results |
|
4 | Update | 2013/03/24 19:47:53 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
5 | Update | 2013/12/02 21:39:17 | Email |
|
6 | Update | 2013/12/02 21:41:07 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
7 | Update | 2016/01/27 18:14:59 | Public title |
|
8 | Update | 2017/05/16 16:35:44 | Name of primary person or sponsor Organization Category of Funding Organization |
|
9 | Update | 2017/05/16 16:39:02 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
10 | Update | 2017/12/05 21:19:16 | Recruitment status |
|
11 | Update | 2017/12/27 16:04:14 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Publication of results |